Radiopharmaceutical deals drive sector growth despite supply crisis
Developers celebrate gains for advances with radiopharmaceuticals while regulators and isotope suppliers work to keep up.
Drug Manufacturers
Purdue and Sackler family agree to $7.4bn national opioid settlement
FDA review designations: tracking 40 years of innovation
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy
“Nothing to do with geopolitics”: WuXi Biologics CEO bullish in face of Biosecure
JPM 2025: WuXi AppTec rebuffs concern about lower GLP-1 demand after Lilly’s low revenue forecast
Charles River CEO reveals drop in 2025 revenue outlook at JP Morgan
Petrovax announces positive results from long-CoV-III-21 trial of Longidaza for long-term pulmonary sequelae of COVID-19
